细胞透性酸核酸反感寡核酸平台针对人类β冠病毒
Soree Park1, Seong Ho Kim1, Mehrangiz Dezhbord1
1Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Frontiers in microbiology
|October 16, 2023
概括
新型改性核酸 (PNA),称为OPNA,对SARS-CoV-2和HCoV-OC43具有强大的抗病毒活性. 这些OPNA克服了细胞内传递的挑战,为抗病毒药物开发提供了一个有前途的新平台.
科学领域:
- 分子生物学分子生物学
- 病毒学 病毒学
- 药物运输 药物运输 药物运输
背景情况:
- 反感性寡核酸 (ASO) 显示出对抗SARS-CoV-2等病毒感染的治疗潜力.
- 核酸 (PNA) 是有希望的ASO候选者,但面临细胞内传递障碍.
- 新的OPNAs被开发用于增强细胞透性和抗病毒功效.
研究的目的:
- 开发和评估用于向和破坏SARS-CoV-2和HCV-OC43RNA基因组的新型修饰PNAs (OPNAs).
- 评估OPNAs对SARS-CoV-2和HCoV-OC43的细胞透性和抗病毒功效.
- 建立OPNA作为开发下一代抗病毒药物的可行平台.
主要方法:
- OPNAs是通过附着在PNA骨干上的阴离子脂质部分合成的.
- HCT-8和Caco-2细胞被感染并用OPNAs进行治疗.
- 病毒RNA水平和核蛋白表达量化使用RT-qPCR和蛋白质分析.
主要成果:
- 针对NSP 14和5' UTR区域的特定OPNA显著降低了病毒标位和基因表达.
- 优化的OPNA证明了对病毒复制和核蛋白生产的剂量依赖抑制.
- 一种OPNA混合物实现了病毒标位和核蛋白水平的八倍以上的降低.
结论:
- OPNAs代表了一个化学稳定的,细胞透的ASO平台,具有很高的结合亲和力.
- OPNAs有效地破坏病毒RNA基因组,显示出显著的抗病毒活性.
- 这项研究强调OPNA作为一个有前途的无载体抗病毒策略,用于未来的流行病准备.
相关概念视频
Subviral Agents
21
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
21
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Viruses with RNA Genomes
36
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
36


